相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
Victor Aboyans et al.
EUROPEAN HEART JOURNAL (2018)
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
Sonia S. Anand et al.
LANCET (2018)
Association of baseline level of physical activity and its temporal changes with incident hypertension and diabetes mellitus
Jong-Young Lee et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2018)
Physical exercise and risk of arterial hypertension and diabetes mellitus. Let's move, it is never too late
Maurizio G. Abrignani
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2018)
The Impact of Liraglutide on Diabetes-Related Foot Ulceration and Associated Complications in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events: Results From the LEADER Trial
Ketan Dhatariya et al.
DIABETES CARE (2018)
Lower extremity arterial disease in patients with diabetes: a contemporary narrative review
Mathilde Nativel et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Risk of lower extremity amputations in people with type 2 diabetes mellitus treated with sodium-glucose co-transporter-2 inhibitors in the USA: A retrospective cohort study
Zhong Yuan et al.
DIABETES OBESITY & METABOLISM (2018)
Empagliflozin and Assessment of Lower-Limb Amputations in the EMPA-REG OUTCOME Trial
Silvio E. Inzucchi et al.
DIABETES CARE (2018)
Peripheral artery disease: epidemiology and global perspectives
F. Gerry R. Fowkes et al.
NATURE REVIEWS CARDIOLOGY (2017)
Effect of a Mediterranean diet on endothelial progenitor cells and carotid intima-media thickness in type 2 diabetes: Follow-up of a randomized trial
Maria Ida Maiorino et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2017)
Pathophysiology of peripheral arterial disease in diabetes mellitus
Shao-ling Yang et al.
JOURNAL OF DIABETES (2017)
Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials
Michael Boehm et al.
LANCET (2017)
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Marc S. Sabatine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease
William R. Hiatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Cardiovascular outcomes for patients with symptomatic peripheral artery disease: A cohort study in The Health Improvement Network (THIN) in the UK
Lucia Cea Soriano et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2017)
Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study
Kamel Mohammedi et al.
CARDIOVASCULAR DIABETOLOGY (2016)
Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 Diabetes
Kamel Mohammedi et al.
DIABETES CARE (2016)
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Lipid-lowering efficacy of the PCSK9 inhibitor evolocumab (AMG 145) in patients with type 2 diabetes: a meta-analysis of individual patient data
Naveed Sattar et al.
LANCET DIABETES & ENDOCRINOLOGY (2016)
The receptor for advanced glycation end products and risk of peripheral arterial disease, amputation or death in type 2 diabetes: a population-based cohort study
Jonas Malmstedt et al.
CARDIOVASCULAR DIABETOLOGY (2015)
Epidemiology of Peripheral Artery Disease
Michael H. Criqui et al.
CIRCULATION RESEARCH (2015)
Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with reduced major adverse cardiovascular events among patients with critical limb ischemia
Ehrin J. Armstrong et al.
VASCULAR MEDICINE (2015)
Global estimates of diabetes prevalence for 2013 and projections for 2035
L. Guariguata et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2014)
Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry
Dharam J. Kumbhani et al.
EUROPEAN HEART JOURNAL (2014)
The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: Risk stratification based on Wound, Ischemia, and foot Infection (WIfI)
Joseph L. Mills et al.
JOURNAL OF VASCULAR SURGERY (2014)
Oxidized low density lipoprotein and total antioxidant capacity in type-2 diabetic and impaired glucose tolerance Saudi men
Essam Eldin Mohamed Nour Eldin et al.
DIABETOLOGY & METABOLIC SYNDROME (2014)
Favorable Effects of Insulin Sensitizers Pertinent to Peripheral Arterial Disease in Type 2 Diabetes Results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial
Andrew D. Althouse et al.
DIABETES CARE (2013)
Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis
F. Gerald R. Fowkes et al.
LANCET (2013)
LOX-1, OxLDL, and Atherosclerosis
Angela Pirillo et al.
MEDIATORS OF INFLAMMATION (2013)
LOX-1 is a novel marker for peripheral artery disease in patients with type 2 diabetes
Michiaki Fukui et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2013)
Achievement of Goals in U.S. Diabetes Care, 1999-2010
Mohammed K. Ali et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Contrast-enhanced magnetic resonance angiography in diabetic patients with infra-genicular peripheral arterial disease: Systematic review
D. A. Healy et al.
INTERNATIONAL JOURNAL OF SURGERY (2013)
YKL-40 is elevated in patients with peripheral arterial disease and diabetes or pre-diabetes
Klaudija Batinic et al.
ATHEROSCLEROSIS (2012)
Supervised Exercise Versus Primary Stenting for Claudication Resulting From Aortoiliac Peripheral Artery Disease Six-Month Outcomes From the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) Study
Timothy P. Murphy et al.
CIRCULATION (2012)
Measurement and Interpretation of the Ankle-Brachial Index A Scientific Statement From the American Heart Association
Victor Aboyans et al.
CIRCULATION (2012)
Functional, Genetic and Biochemical Biomarkers of Peripheral Arterial Disease
M. Charakida et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Associations Between Conventional Cardiovascular Risk Factors and Risk of Peripheral Artery Disease in Men
Michel M. Joosten et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Everyone under statin?
Helene Vaillant-Roussel et al.
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2012)
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
B. Mihaylova et al.
LANCET (2012)
Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications
Ravichandran Ramasamy et al.
YEAR IN DIABETES AND OBESITY (2011)
Outcomes Among Hypertensive Patients With Concomitant Peripheral and Coronary Artery Disease Findings From the INternational VErapamil-SR/Trandolapril STudy
Anthony A. Bavry et al.
HYPERTENSION (2010)
Aspirin for Prevention of Cardiovascular Events in a General Population Screened for a Low Ankle Brachial Index A Randomized Controlled Trial
F. Gerald R. Fowkes et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Advanced glycation endproducts alter functions and promote apoptosis in endothelial progenitor cells through receptor for advanced glycation endproducts mediate overpression of cell oxidant stress
Jianfei Chen et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
10-year follow-up of intensive glucose control in type 2 diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease
Jill Belch et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography for diagnosis and assessment of symptomatic, lower limb peripheral arterial disease:: systematic review
Ros Collins et al.
BMJ-BRITISH MEDICAL JOURNAL (2007)
Oxidative-stress-mediated arterial dysfunction in patients with peripheral arterial disease
L. Loffredo et al.
EUROPEAN HEART JOURNAL (2007)
High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study
L. Prompers et al.
DIABETOLOGIA (2007)
Peripheral arterial disease and risk of cardiac death in type 2 diabetes - The Fremantle Diabetes Study
PE Norman et al.
DIABETES CARE (2006)
Meta-analysis: Glycosylated hemoglobin and cardiovascular disease in diabetes mellitus
E Selvin et al.
ANNALS OF INTERNAL MEDICINE (2004)
Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes
G Basta et al.
CARDIOVASCULAR RESEARCH (2004)
UKPDS 59: Hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes
AI Adler et al.
DIABETES CARE (2002)
分享论文
